Prometheus Biosciences
RXDX
#2012
Rank
$9.55 B
Marketcap
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)

Revenue for Prometheus Biosciences (RXDX)

Revenue in 2023 (TTM): $3.99 Million USD

According to Prometheus Biosciences's latest financial reports the company's current revenue (TTM ) is $3.99 Million USD. In 2022 the company made a revenue of $6.8 Million USD an increase over the revenue in the year 2021 that were of $3.12 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prometheus Biosciences from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $3.99 M-41.33%
2022 $6.8 M117.61%
2021 $3.12 M154.6%
2020 $1.22 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Epizyme
EPZM
$53 M 1,226.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.10 B 2,574.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Akebia Therapeutics
AKBA
$0.22 B 5,533.82%๐Ÿ‡บ๐Ÿ‡ธ USA